Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial evaluating withdrawal of disease-modifying antirheumatic drugs in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056 [Phase 2]
Phase 2 open-label study of CDP6038 (Olokizumab) in rheumatoid arthritis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Novel Form of Acquired Long QT Syndrome [Phase 4]
A Phase 4 clinical trial update for a novel form addressing Acquired Long QT Syndrome with additional conditions listed; current status is u…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial update for two doses of ABX464 in moderate to severe rheumatoid arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Tolerance and Effectiveness of Cell Therapy by Autologous Apoptotic Cells in the Treatment of Rheumatoid Arthritis [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating autologous apoptotic cell therapy for rheumatoid arthritis; current status unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: MTX Hold During Covid-19 Booster [Phase 3]
Phase 3 clinical trial update investigating hold of methotrexate during COVID-19 booster in rheumatoid arthritis patients.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate [Phase 2]
Phase 2 study evaluating CE-224,535 taken twice daily for rheumatoid arthritis in patients not fully responsive to methotrexate; trial compl…
-
FDA approval · 2022-03-22FDA Approved: IBUPROFEN — Supplemental Application (Aurohealth LLC)
The FDA approved a supplemental application for ibuprofen filed by Aurohealth LLC, authorizing the generic ibuprofen product.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Tripterygium Wilfordii Hook F and Methotrexate for Postmenopausal Women With Rheumatoid Arthritis [Phase 2, Phase 3]
A Phase 2/3 trial evaluating Tripterygium wilfordii Hook F in combination with methotrexate for postmenopausal women with rheumatoid arthrit…
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis [Phase 1, Phase 2]
A Phase 1/2a trial evaluating the safety of HB-adMSCs for rheumatoid arthritis has completed enrollment and posted results.
-
FDA approval · 2022-03-18FDA Approved: BROMFENAC — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for bromfenac from Aurobindo Pharma Limited, enabling a generic bromfenac product to enter the market.…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Comorbidities and Outcomes in Early Rheumatoid Arthritis
A completed clinical trial updating comorbidities and outcomes in early rheumatoid arthritis, with posted results.
-
FDA approval · 2022-03-11FDA Approved: NAPROXEN — Supplemental Application (Granules India Ltd)
FDA approved a supplemental application for naproxen sodium granules from Granules India Ltd, resulting in an approved supplemental request …
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: MYL-1401A Efficacy and Safety Comparability Study to Humira® [Phase 3]
Phase 3 trial comparing MYL-1401A to Humira for psoriasis, arthritis, and psoriatic arthritis has completed.
-
FDA approval · 2022-03-09FDA Approved: CELECOXIB — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Celecoxib from Micro Labs Limited under an ANDA.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: Safety and Efficacy of AMG 827 in Subjects With RA [Phase 2]
Phase 2 clinical trial of AMG 827 in rheumatoid arthritis was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis [Phase 1, Phase 2]
A clinical trial update on tolerogenic dendritic cell therapy for rheumatoid arthritis spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066) [Phase 3]
Phase 3 clinical trial update evaluating the safety of etoricoxib in osteoarthritis and rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072) [Phase 3]
Phase 3 trial comparing an investigational drug to an approved drug in rheumatoid arthritis has completed.
-
FDA approval · 2022-02-08FDA Approved: PIROXICAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Piroxicam submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2022-02-02FDA Approved: CYCLOSPORINE — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved Mylan Pharmaceuticals' original application for cyclosporine, a generic immunosuppressant product. This makes a generic cyc…
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis [Phase 3]
An extension study (Phase 3) in participants with moderate to severe rheumatoid arthritis has completed enrollment and posted results.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) [Phase 3]
Long-term evaluation results from a Phase 3 trial of sarilumab in rheumatoid arthritis have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants [Phase 1]
Phase 1 study evaluating potential OATP-mediated drug-drug interactions between filgotinib and statins in healthy participants; completed wi…
-
FDA approval · 2022-01-14FDA Approved: SOVUNA — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved SOVUNA (hydroxychloroquine sulfate) under an original application by ANI Pharmaceuticals, Inc.